SOPHiA GENETICS S.A. (SOPH) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
SOPHiA GENETICS S.A. (SOPH) Earnings Overview
As of June 28, 2026, SOPHiA GENETICS S.A. (SOPH) reported trailing twelve-month net income of -$81M, reflecting -23.2% year-over-year growth. The company earned $-1.14 per diluted share over the past four quarters, with a net profit margin of -102.2%.
Looking at the long-term picture, SOPH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$34M in fiscal 2019.
SOPHiA GENETICS S.A. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NTRA (-$226M net income, -9.0% margin), EXAS (-$208M net income, -6.4% margin), VCYT ($88M net income, 12.8% margin), SOPH has room to improve margins relative to the peer group. Compare SOPH vs NTRA →
SOPH Earnings vs Peers
Earnings metrics vs comparable public companies
SOPH Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$79M | -26.4% | -$71M | $-1.17 | -102.2% | -91.8% |
| 2024 | -$62M | +20.9% | -$67M | $-0.95 | -95.9% | -102.1% |
| 2023 | -$79M | +9.7% | -$75M | $-1.22 | -126.6% | -120.0% |
| 2022 | -$87M | -18.7% | -$88M | $-1.36 | -183.9% | -184.7% |
| 2021 | -$74M | -87.3% | -$71M | $-1.33 | -182.1% | -176.7% |
| 2020 | -$39M | -16.4% | -$37M | $-0.82 | -138.5% | -131.6% |
| 2019 | -$34M | - | -$32M | $-0.53 | -133.2% | -127.3% |
Download Data
Export SOPH earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SOPH — Frequently Asked Questions
Quick answers to the most common questions about buying SOPH stock.
What is SOPH earnings per share (EPS)?
SOPH trailing twelve-month (TTM) diluted EPS is $-1.14, reflecting -23.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is SOPHiA GENETICS S.A.'s net income?
SOPHiA GENETICS S.A. (SOPH) trailing twelve-month net income is $-81M as of 2025. Earnings declined -23.2% year-over-year.
Is SOPH profitable?
SOPH is not currently profitable on a TTM basis, reporting a net loss of $-81M. Net margin is -102.2%. Investors should monitor for a return to profitability.
What is SOPH's earnings growth rate?
SOPH compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are SOPH's profit margins?
SOPHiA GENETICS S.A. net profit margin is -102.2%, operating margin is -91.8%, and gross margin is +61.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is -110.0%.
Is SOPH growing earnings?
SOPH earnings are declining — EPS fell -23.2% year-over-year. TTM net income dropped to $-81M. This contrasts with the 5-year CAGR of N/A.
What was SOPH's best earnings year?
SOPHiA GENETICS S.A.'s highest annual net income on record is $-34M, achieved in fiscal year 2019. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were SOPH's earnings last quarter?
SOPH's most recent reported quarter was Q1 2026. Net income was $-19M with diluted EPS of $-0.27. For a full breakdown of all quarters, see the quarterly earnings table on this page.